Overview

Atorvastatin as Adjunctive Therapy in COVID-19

Status:
Recruiting

Trial end date:
2022-05-08

Target enrollment:

Participant gender:

Summary

Objective: To assess whether adjunctive therapy of COVID-19 infection with atorvastatin reduces the deterioration in hospitalized patients and improves clinical outcome.

Phase:

Phase 2

Details

Lead Sponsor:

Mount Auburn Hospital

Treatments:

Atorvastatin